| Defibrillator implantation in patients with nonischemic systolic heart failure L Køber, JJ Thune, JC Nielsen, J Haarbo, L Videbæk, E Korup, G Jensen, ... New England Journal of Medicine 375 (13), 1221-1230, 2016 | 1721 | 2016 |
| Atlas of the clinical genetics of human dilated cardiomyopathy J Haas, KS Frese, B Peil, W Kloos, A Keller, R Nietsch, Z Feng, S Müller, ... European heart journal 36 (18), 1123-1135, 2015 | 565 | 2015 |
| Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients R Nielsen, N Møller, LC Gormsen, LP Tolbod, NH Hansson, J Sorensen, ... Circulation 139 (18), 2129-2141, 2019 | 363 | 2019 |
| Surface electrocardiogram to predict outcome in candidates for cardiac resynchronization therapy: a sub‐analysis of the CARE‐HF trial R Gervais, C Leclercq, A Shankar, S Jacobs, H Eiskjær, A Johannessen, ... European journal of heart failure 11 (7), 699-705, 2009 | 296* | 2009 |
| Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure UC Hoppe, JM Casares, H Eiskjær, A Hagemann, JGF Cleland, ... Circulation 114 (1), 18-25, 2006 | 261 | 2006 |
| Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and … PD Jensen, FT Jensen, T Christensen, H Eiskjær, U Baandrup, JL Nielsen Blood 101 (11), 4632-4639, 2003 | 217 | 2003 |
| Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure M Halbirk, H Nørrelund, N Møller, JJ Holst, O Schmitz, R Nielsen, ... American Journal of Physiology-Heart and Circulatory Physiology 298 (3 …, 2010 | 197 | 2010 |
| Rationale and design of DanGer shock: Danish-German cardiogenic shock trial NJ Udesen, JE Møller, MG Lindholm, H Eiskjær, A Schäfer, N Werner, ... American heart journal 214, 60-68, 2019 | 187 | 2019 |
| Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study NH Andersen, PL Poulsen, ST Knudsen, SH Poulsen, H Eiskjær, ... Diabetes care 28 (2), 273-277, 2005 | 171 | 2005 |
| Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure MB Elming, JC Nielsen, J Haarbo, L Videbæk, E Korup, J Signorovitch, ... Circulation 136 (19), 1772-1780, 2017 | 169 | 2017 |
| Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial L Gullestad, M Iversen, SA Mortensen, H Eiskjær, GC Riise, L Mared, ... Transplantation 89 (7), 864-872, 2010 | 163 | 2010 |
| Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with Type II diabetes mellitus: a Doppler tissue tracking and strain rate … NH Andersen, SH Poulsen, H Eiskjaer, PL Poulsen, CE Mogensen Clinical Science 105 (1), 59-66, 2003 | 163 | 2003 |
| Everolimus initiation and early calcineurin inhibitor withdrawal in heart transplant recipients: a randomized trial AK Andreassen, B Andersson, F Gustafsson, H Eiskjaer, G Rådegran, ... American journal of transplantation 14 (8), 1828-1838, 2014 | 142 | 2014 |
| Renal effects of brain natriuretic peptide in patients with congestive heart failure KT JENSEN, H EISKJÆR, J CARSTENS, EB PEDERSEN Clinical science 96 (1), 5-15, 1999 | 119 | 1999 |
| Physicians' guideline adherence is associated with long‐term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY international … M Komajda, J Schöpe, S Wagenpfeil, L Tavazzi, M Böhm, P Ponikowski, ... European Journal of Heart Failure 21 (7), 921-929, 2019 | 112 | 2019 |
| Dilated Cardiomyopathy Due to BLC2-Associated Athanogene 3 (BAG3) Mutations F Domínguez, S Cuenca, Z Bilińska, R Toro, E Villard, R Barriales-Villa, ... Journal of the American College of Cardiology 72 (20), 2471-2481, 2018 | 108 | 2018 |
| Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment C Aalkjær, H Eiskjær, MJ Mulvany, B Jespersen, T Kjært, SSS Sorensen, ... Journal of hypertension 7 (4), 305-310, 1989 | 105 | 1989 |
| Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: three-year results from the randomized SCHEDULE study AK Andreassen, B Andersson, F Gustafsson, H Eiskjaer, G Rådegran, ... American Journal of Transplantation 16 (4), 1238-1247, 2016 | 96 | 2016 |
| Effect of everolimus introduction on cardiac allograft vasculopathy—results of a randomized, multicenter trial S Arora, T Ueland, B Wennerblom, V Sigurdadottir, H Eiskjær, HE Bøtker, ... Transplantation 92 (2), 235-243, 2011 | 88 | 2011 |
| Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial L Gullestad, SA Mortensen, H Eiskjær, GC Riise, L Mared, Ø Bjørtuft, ... Transplantation 90 (12), 1581-1589, 2010 | 83 | 2010 |
